On April 1, 2025, Lantheus Holdings completed its acquisition of Evergreen Theragnostics for approximately $275 million, with potential additional milestone payments of up to $727.5 million. The merger was approved by both companies' Boards of Directors and involves Evergreen becoming a wholly owned subsidiary of Lantheus Medical.